Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,551,814 papers from all fields of science
Search
Sign In
Create Free Account
rivastigmine
Known as:
Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
, (S)-N-Ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate
, M-((S)-1-(Dimethylamino)ethyl)phenyl Ethylmethylcarbamate
Expand
A carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
18 relations
24 HR rivastigmine 0.192 MG/HR Transdermal System
24 HR rivastigmine 0.192 MG/HR Transdermal System [Exelon]
Alzheimer's Disease
Carbamates
Expand
Broader (2)
Cholinesterase Inhibitors
Neuroprotective Agents
Narrower (1)
Exelon
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
BZYX, a novel acetylcholinesterase inhibitor, significantly improved chemicals-induced learning and memory impairments on rodents and protected PC12 cells from apoptosis induced by hydrogen peroxide.
Jing Zhang
,
Difeng Zhu
,
+6 authors
Qiaojun He
European Journal of Pharmacology
2009
Corpus ID: 21921996
Highly Cited
2007
Highly Cited
2007
Characterization of reversible and pseudo-irreversible acetylcholinesterase inhibitors by means of an immobilized enzyme reactor.
M. Bartolini
,
V. Cavrini
,
V. Andrisano
Journal of Chromatography A
2007
Corpus ID: 36355859
Highly Cited
2007
Highly Cited
2007
Changes in brain 11C–nicotine binding sites in patients with mild Alzheimer’s disease following rivastigmine treatment as assessed by PET
A. Kadir
,
T. Darreh-Shori
,
O. Almkvist
,
A. Wall
,
B. Långström
,
A. Nordberg
Psychopharmacology
2007
Corpus ID: 35810483
RationaleMarked reduction in the cortical nicotinic acetylcholine receptors is observed in the brain of patients suffering from…
Expand
Review
2006
Review
2006
Do cholinergic therapies have disease-modifying effects in Alzheimer’s disease?
M. Sabbagh
,
M. Farlow
,
N. Relkin
,
T. Beach
Alzheimer's & Dementia
2006
Corpus ID: 5826421
Highly Cited
2004
Highly Cited
2004
Prediction of treatment response to rivastigmine in Alzheimer’s dementia
Georg Adler
,
S. Brassen
,
K. Chwalek
,
B. Dieter
,
M. Teufel
Journal of Neurology Neurosurgery & Psychiatry
2004
Corpus ID: 31036315
Objectives: To predict the treatment response to rivastigmine in patients with Alzheimer’s dementia using neuropsychological and…
Expand
Highly Cited
2004
Highly Cited
2004
Preserved cognitive function after 12 months of treatment with rivastigmine in mild Alzheimer's disease in comparison with untreated AD and MCI patients
O. Almkvist
,
O. Almkvist
,
T. Darreh-Shori
,
E. Stefanova
,
R. Spiegel
,
A. Nordberg
European Journal of Neurology
2004
Corpus ID: 13162887
Cholinesterase inhibitors (ChEIs) have shown positive symptomatic effects on cognition, activities of daily living, and behavior…
Expand
2003
2003
Influence of cholinergic circuitries in generation of high-frequency somatosensory evoked potentials
D. Restuccia
,
G. Marca
,
Massimiliano Valeriani
,
M. Rubino
,
P. Tonali
Clinical Neurophysiology
2003
Corpus ID: 42800212
Review
2002
Review
2002
CLINICAL AND COST-EFFECTIVENESS OF DONEPEZIL, RIVASTIGMINE, AND GALANTAMINE FOR ALZHEIMER'S DISEASE
A. Clegg
,
J. Bryant
,
+4 authors
N. Waugh
International Journal of Technology Assessment in…
2002
Corpus ID: 29864790
Objectives: Systematic review of the clinical and cost-effectiveness of donepezil, rivastigmine, and galantamine for people…
Expand
Review
2001
Review
2001
Muscarinic agonists and antagonists in the treatment of Alzheimer's disease.
W. Greenlee
,
J. Clader
,
+21 authors
K. Cox
Il Farmaco
2001
Corpus ID: 34206300
Review
1963
Review
1963
Action of Trace Elements on the Metabolism of Fluoride
W. Büttner
1963
Corpus ID: 72713622
Many studies in laboratory animals have shown that the absorption of fluoride can be influenced by dietary factors, thus…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE